Asian shares retreat after Trump's order imposing new tariffs on 68 countries and the EU
Trump's order, which pushed back the tariff deadline earlier set on Aug. 1, has injected a new dose of uncertainty in an already uncertain process.
Japan's Nikkei 225 slid 0.4 % to 40,914.66 while South Korea's Kospi tumbled 2.8% to 3,154.53.
Hong Kong's Hang Seng index trimmed earlier losses, shedding 0.2% to 24,726.38, while the Shanghai Composite slipped 0.1% to 3,570.21.
Australia's S&P ASX 200 shed 0.8% to 8,676.80, India's BSE Sensex fell 0.4% to 81,185.58 and Taiwan's TAIEX slid 0.4% to 23,453.56.
"US and European equity futures are pointing negative, Asian stocks are taking a beating and the DXY index is still rising,' Benjamin Picton, senior market strategist at Rabo Bank, said in a commentary about Trump's new order updating reciprocal tariff rates.
"The USA is cherry-picking high value-add industry for its own economy while forcing trading partners to grant preferential market access for its exports and supply it with cheap imports. Make no mistake, this is imperial trade,' he added.
Mizuho Bank noted in "somewhat a turn of the tables, Asia (and in particular Southeast Asia) which was harder hit post-'Liberation Day' now appear to be in a better position by virtue of tariffs differentials though intra-regional differences remain small.'
On Wall Street on Thursday, stocks capped the trading day with more losses after an early big tech rally faded and a health care sector pullback led the market lower.
The S&P 500 fell 0.4%, its third straight decline. The benchmark index, which is just below the record high it set Monday, notched a 2.2% gain for the month of July and is up 7.8% so far this year.
The Dow Jones Industrial Average lost 0.7% and the Nasdaq composite closed less than 0.1% lower.
Roughly 70% of stocks in the S&P 500 lost ground, with health care companies accounting for the biggest drag on the market.
Health care stocks sank after the White House released letters asking big pharmaceutical companies to cut prices and make other changes in the next 60 days. Eli Lilly & Co. fell 2.6%, UnitedHealth Group slid 6.2% and Bristol-Myers Squibb dropped 5.8%.
Gains by some big technology stocks with hefty values helped temper the impact of the broader market's decline.
Meta Platforms surged 11.3% after the parent company of Facebook and Instagram crushed Wall Street's sales and profit targets even as the company continues to pour billions of dollars into artificial intelligence.
Microsoft climbed 3.9% after posting better results than analysts expected. The software pioneer also gave investors an encouraging update on its Azure cloud computing platform, which is a centerpiece of the company's artificial intelligence efforts.
Big Tech companies have regularly been the driving force behind much of the market's gains over enthusiasm for the future of artificial intelligence.
In other dealings Friday, U.S. benchmark crude oil lost 5 cents to $69.21 per barrel, while Brent crude, the international standard, shed 3 cents to $71.67 per barrel.
The U.S. dollar climbed to 150.68 Japanese yen from 150.67 yen. The euro rose to $1.1418 from $1.1421.
___
Associated Press Business Writers Damian J. Troise and Alex Veiga contributed
Teresa Cerojano, The Associated Press
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
10 minutes ago
- CNBC
India to maintain Russian oil imports despite Trump threats, government sources say
India will keep purchasing oil from Russia despite U.S. President Donald Trump's threats of penalties, two Indian government sources told Reuters on Saturday, not wishing to be identified due to the sensitivity of the matter. On top of a new 25% tariff on India's exports to the U.S., Trump indicated in a Truth Social post last month that India would face additional penalties for purchases of Russian arms and oil. On Friday, Trump told reporters he had heard that India would no longer be buying oil from Russia. But the sources said there would be no immediate changes. "These are long-term oil contracts," one of the sources said. "It is not so simple to just stop buying overnight." Justifying India's oil purchases from Russia, a second source said India's imports of Russian grades had helped avoid a global surge in oil prices, which have remained subdued despite Western curbs on the Russian oil sector. Unlike Iranian and Venezuelan oil, Russian crude is not subject to direct sanctions, and India is buying it below the current price cap fixed by the European Union, the source said. The New York Times also quoted two unnamed senior Indian officials on Saturday as saying there had been no change in Indian government policy. Indian government authorities did not respond to Reuters' request for official comment on its oil purchasing intentions. However, during a regular press briefing on Friday, foreign ministry spokesperson Randhir Jaiswal said India has a "steady and time-tested partnership" with Russia. "On our energy sourcing requirements ... we look at what is there available in the markets, what is there on offer, and also what is the prevailing global situation or circumstances," he said. The White House did not immediately respond to requests for comment. Trump, who has made ending Russia's war in Ukraine a priority of his administration since returning to office this year, has expressed growing impatience with Russian President Vladimir Putin in recent weeks. He has threatened 100% tariffs on U.S. imports from countries that buy Russian oil unless Moscow reaches a major peace deal with Ukraine. Russia is the leading supplier to India, the world's third-largest oil importer and consumer, accounting for about 35% of its overall supplies. India imported about 1.75 million barrels per day of Russian oil from January to June this year, up 1% from a year ago, according to data provided to Reuters by sources. But while the Indian government may not be deterred by Trump's threats, sources told Reuters this week that Indian state refiners stopped buying Russian oil after July discounts narrowed to their lowest since 2022 - when sanctions were first imposed on Moscow - due to lower Russian exports and steady demand. Indian Oil Corp, Hindustan Petroleum Corp, Bharat Petroleum Corp and Mangalore Refinery Petrochemical Ltd have not sought Russian crude in the past week or so, four sources told Reuters. Nayara Energy - a refinery majority-owned by Russian entities, including oil major Rosneft, and major buyer of Russian oil - was recently sanctioned by the EU. Nayara's chief executive resigned following the sanctions, and three vessels laden with oil products from Nayara Energy have yet to discharge their cargoes, hindered by the new EU sanctions, Reuters reported last week.
Entrepreneur
37 minutes ago
- Entrepreneur
Built to Move
In the West, e-bikes outsell scooters and motorcycles, we're trying to create that same mindset here, says Kunal Gupta, co-founder, Emotorad This story appears in the July 2025 issue of Entrepreneur India. Subscribe » You're reading Entrepreneur India, an international franchise of Entrepreneur Media. In 2020, when the world was slowing down, a new-age electric mobility brand from Pune quietly picked up speed. What began as a pivot during the pandemic, selling high-end e-bikes locally after a shipment for the UK got stuck, has now grown into one of India's fastest-scaling E-Bike startups. Emotorad, co-founded by Kunal Gupta, Rajib Gangopadhyay, Aditya Oza, and Sumedh Batteward. Today commands a 70 per cent share of India's electric bicycle market and exports to 18 countries across the globe. Before Emotorad, Gupta had already built and exited his first startup, MyRide, a bike rental company for college students. That venture led him to co-found and run operations at OnBike, a Zoomcar-style service for two-wheelers that scaled to over 14,000 vehicles across 11 cities. "We learned a lot about how tier 3 and tier 4 Indians were migrating to cities and earning livelihoods through mobility platforms," he recalls. At the core of Emotorad's success lies its commitment to in house innovation. The company designs and manufactures key components of its EV powertrains including batteries, motors, char gers, displays, and the software that makes them work together. "We've filed over 11 patents across our powertrain technologies. The systems we've built are 18–20 per cent more efficient than the market average," Gupta says. This vertical integration, Gupta believes, is what makes their products stand apart. "It's not just about one better battery or frame. It's the entire mechanical design, ergonomics, and software that make our bikes superior," he says. Products like the Doodle have be come category-defining, drawing attention both domestically and overseas. While electric cars and scoot ers often grab headlines, e-bikes remain an underappreciated part of the EV narrative in India. Gupta says one major hurdle is the public misconception that e-bikes are "cheating" fitness. "In fact, our data shows that e-bike users travel 3 to 4 times more than regular cyclists. That's more exercise, not less. Plus, you can track calories and make your ride part of a healthy routine," he points out. Despite 2.5 lakh units sold, many Indian consumers still don't know that high-quality e-bikes are made and used right here. "In the West, e-bikes outsell scooters and motorcycles. We're trying to create that same mindset here," says Gupta. Today, EM exports to 18 countries including the US, UK, Australia, Japan, and UAE. Gupta believes this is just the beginning. Gupta says the company may raise capital again in the next 12–18 months.
Bloomberg
2 hours ago
- Bloomberg
Modi Renews Call for Indians to Buy Local Products Amid Tariffs
Indian Prime Minister Narendra Modi intensified his push to prioritize locally made products, amid global economic instability in the wake of US trade tariffs. Modi urged citizens to buy, sell and promote Indian products, citing global economic uncertainty but without referring to US tariffs.
